FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077901 [Registered on: 10/12/2024] Trial Registered Prospectively
Last Modified On: 09/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical trial to evaluate the effect of yastimadhu ksheera paka and kushmanda rasayana granules in artists with social phobia  
Scientific Title of Study   A comparative clinical study to evaluate the tranquilizing effect of yastimadhu ksheera paka and kushmanda rasayana granules in artists with social phobia. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shantala S Bharbhari 
Designation  MD Scholar (Manasaroga) 
Affiliation  Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady Udupi 
Address  OPD3 Dept of Manasaroga Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady Udupi

Udupi
KARNATAKA
574118
India 
Phone  8496060565  
Fax    
Email  shantalasb98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vijayendra G Bhat 
Designation  BAMS MD(Ayu) 
Affiliation  Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady Udupi 
Address  OPD3 Dept of Manasaroga Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady Udupi

Udupi
KARNATAKA
574118
India 
Phone  9448139919  
Fax    
Email  ayurvijay25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shantala S Bharbhari 
Designation  MD Scholar (Manasaroga) 
Affiliation  Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady Udupi 
Address  OPD3 Dept of Manasaroga Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady, Udupi

Udupi
KARNATAKA
574118
India 
Phone  8496060565  
Fax    
Email  shantalasb98@gmail.com  
 
Source of Monetary or Material Support  
Shri Dharmasthala Manjunatheshwar Ayurveda Pharmacy , Laxminaryana Nagar P.O. kuthpady Udupi, karnataka, India- 574118 
 
Primary Sponsor  
Name  nil 
Address  nil 
Type of Sponsor  Other [nil] 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shantala S Bharbhari  Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady, Udupi  OPD3 Dept of Manasaroga Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady, Udupi
Udupi
KARNATAKA 
08496060565

shantalasb98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Clearance Committee Human   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F401||Social phobias. Ayurveda Condition: bhaya,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Yastimadhu Ksheera Paka, Reference: Charaka Samhitha Chikithsa sthana; Karaprachatiya Rasayana; chapter 1.3, verse no 30, Route: Oral, Dosage Form: Ksheerpaka, Dose: 48(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Kushmanda Rasayana Granules, Reference: The Ayurvedic Formulary of India (2nd ed.) part 1.Delhi: The controller of Publications Civil Lines; 2003; 36, Route: Oral, Dosage Form: Khanda /Granules, Dose: 12(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: Ksheera), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  1.Subject fulfilling the DSM-5 Diagnostic criteria [for Social Phobia].
2.Artists – stage performers (Dancers, Singers, musician, debate, pick and speak, pick and act)
3.Age group: 18 -30yrs
4.Participants who are willing and able to provide informed consent.
 
 
ExclusionCriteria 
Details  Subjects suffering from any other psychiatric and any organic disorders, lactating and pregnant Women will be excluded. 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Assessment will be done by scoring subjective parameters by assessing on 0th, 14th and 28th day.
Severity Measure for Social Anxiety Disorder (Social Phobia). According to American psychiatric association.
Hamilton’s Anxiety Rating Scale.
WHO Quality of life Scale-Brief.
Manasika bhava scale

Scored parameters will be analysed statistically after the treatment. All the subjective parameters and scales will be assessed using Wilcoxon signed rank test within the groups and Mann-Whitney U test in between the groups.
 
Observation will be done on 0th , 14th and 28th day
 
 
Secondary Outcome  
Outcome  TimePoints 
quality of life   0th and 28th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   31/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is Raandomised open labelled parallel group study comparing the safety and efficacy of the trial drug Group A – Yastimadhu Ksheera Paka 1pala before food morning Group B – Kushmanda Rasayana Granules 12grams with milk on empty stomach early morning for 28 days in each group and study will be conducted in Shri Dharmasthala Manjunatheshwara college of Ayurveda Kuthpady Udupi, Karnataka, India. The primary measures will be assessed through Severity Measure for Social Anxiety Disorder (Social Phobia). According to American psychiatric association, Hamilton’s Anxiety Rating Scale, Manasika bhava scale. The secondary outcome majors will be assessed based on the WHO Quality of life Scale-Brief hence the study is an effort to prove the efficacy of Yastimadhu Ksheera Paka and Kushmanda Rasayana Granules in artists with social phobia.

 
Close